Pieter Wolters

IsoTis NV manufactures, markets and sells a range of bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Bilthoven, the Netherlands

IsoTis, Inc. designs, manufactures and sells bone graft substitutes and other devices. The company was founded on November 15, 2006 and is headquartered in Plainsboro, NJ.

OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA.

IsoTis Orthobiologics Inc. develops, manufactures and markets proprietary products for the treatment of musculoskeletal diseases and disorders. Its products include bone graft substitutes that promote the regeneration of bone and are used to repair natural, trauma-related and surgically-created defects common in orthopedic procedures, including spinal fusions. The company was founded in 2003 and is headquartered in Irvine, CA.

DSM Venturing BV (DSM Venturing) is the venture capital arm of Royal DSM NV in the Netherlands founded in 2001. DSM Venturing BV is headquartered in Geleen.

Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark.

Essential Medical, Inc. designs, develops, and markets medical and surgical devices. It specializes in vascular closure devices that seals the opening created from cardiac catheterizations in leg arteries. The company was founded by Gary S. Roubin and Greg A. Walters in 2010 and is headquartered in Wayne, PA.

Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada.

Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA.